SE7612295L - Antibiotikum - Google Patents

Antibiotikum

Info

Publication number
SE7612295L
SE7612295L SE7612295A SE7612295A SE7612295L SE 7612295 L SE7612295 L SE 7612295L SE 7612295 A SE7612295 A SE 7612295A SE 7612295 A SE7612295 A SE 7612295A SE 7612295 L SE7612295 L SE 7612295L
Authority
SE
Sweden
Prior art keywords
deacetyl
antibiotics
gram
thienamycin
antibiotic
Prior art date
Application number
SE7612295A
Other languages
English (en)
Swedish (sv)
Inventor
J S Kahan
F M Kahan
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of SE7612295L publication Critical patent/SE7612295L/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/80—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/182—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
    • C12P17/184—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system containing a beta-lactam ring, e.g. thienamycin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SE7612295A 1975-11-24 1976-11-04 Antibiotikum SE7612295L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63456075A 1975-11-24 1975-11-24

Publications (1)

Publication Number Publication Date
SE7612295L true SE7612295L (sv) 1977-05-25

Family

ID=24544292

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7612295A SE7612295L (sv) 1975-11-24 1976-11-04 Antibiotikum

Country Status (16)

Country Link
JP (1) JPS5265295A (da)
AR (1) AR224224A1 (da)
AU (1) AU510252B2 (da)
BE (1) BE848349A (da)
CH (1) CH625803A5 (da)
DE (1) DE2652678A1 (da)
DK (1) DK497476A (da)
ES (1) ES453508A1 (da)
FR (1) FR2351979A1 (da)
GB (1) GB1561108A (da)
GR (1) GR61407B (da)
HU (1) HU175266B (da)
NL (1) NL7612932A (da)
PT (1) PT65845B (da)
SE (1) SE7612295L (da)
ZA (1) ZA766986B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7800979L (sv) * 1977-02-11 1978-08-12 Merck & Co Inc Antibiotikum
NL7800957A (nl) * 1977-02-11 1978-08-15 Merck & Co Inc Antibioticum desacetyl 890 a10, werkwijze ter bereiding daarvan en farmaceutische preparaten die dit antibioticum bevatten.
US4162193A (en) * 1977-08-19 1979-07-24 Merck & Co., Inc. Enzymatic cleavage of N-acyl-thienamycins
NZ190994A (en) 1978-07-24 1981-10-19 Merck & Co Inc Z-2-acylamino-3-monosubstituted propenoates
DE2965923D1 (en) * 1979-08-28 1983-08-25 Merck & Co Inc Process for purifying thienamycin
DE3146190A1 (de) * 1981-11-21 1983-06-16 Hoechst Ag, 6230 Frankfurt Isolierung von chemisch instabilen antibiotika aus fermentationsloesungen
US10695322B2 (en) 2016-01-29 2020-06-30 The Johns Hopkins University Inhibitors of bacterial growth

Also Published As

Publication number Publication date
NL7612932A (nl) 1977-05-26
PT65845A (en) 1976-12-01
FR2351979B1 (da) 1982-08-13
JPS5265295A (en) 1977-05-30
BE848349A (fr) 1977-05-16
DE2652678A1 (de) 1977-06-02
PT65845B (en) 1978-10-10
DK497476A (da) 1977-05-25
AR224224A1 (es) 1981-11-13
ZA766986B (en) 1978-06-28
AU1964576A (en) 1978-05-25
AU510252B2 (en) 1980-06-19
FR2351979A1 (fr) 1977-12-16
HU175266B (hu) 1980-06-28
ES453508A1 (es) 1978-03-01
GR61407B (en) 1978-11-11
GB1561108A (en) 1980-02-13
CH625803A5 (en) 1981-10-15

Similar Documents

Publication Publication Date Title
ES477591A1 (es) Procedimiento para la obtencion de preparados farmaceuticos que contienen un derivado de cefem.
ES480915A1 (es) Un procedimiento para la preparacion de antibioticos de ce- falosporinas.
SE7902954L (sv) Tiazolylettiksyraforeningar
SE7706877L (sv) Kemiska mellanprodukter
NO834146L (no) Fremgangsmaate for fremstilling av epimert azahomoerytromycin a
ES499485A0 (es) Procedimiento para la preparacion de derivados de cefalospo-rina
SE7611047L (sv) Forfarande for framstellning av antibakteriella emnen
ES408972A1 (es) Un procedimiento de preparacion de un compuesto de cefalos-porina.
SE7704301L (sv) Antibiotika
EP0196628A3 (en) Ansamycin antibioticum, microbiological process for its preparation and its use as a medicament
SE7612962L (sv) Tienamycinderivat
ES436103A1 (es) Un procedimiento para la preparacion de antibioticos.
SE7508570L (sv) Forfarande for framstellning av cefalosporinforeningar
IL35875A (en) Pharmaceutical compositions for the treatment of microbial infections containing an n-(3-carboxy-propionyl)glutamic acid derivative
ES8105147A1 (es) Procedimiento para la obtencion de composiciones farmaceuti-cas de actividad antibacteriana
SE7909501L (sv) Cefalosporin-antibiotika
JPS54154785A (en) Cephem derivative and its manufacture
GB1531141A (en) Beta-lactam antibiotics
SE7612963L (sv) Tienamycinderivat
GB1028563A (en) Antibacterial derivative of 7-aminocephalosporanic acid
GB1470329A (en) Antibiotic derivatives of xk-62-2 and method of production thereof
GB1504589A (en) Substituted cephalosporin antibiotics
SE7612960L (sv) Tienamycinderivat
SE7712645L (sv) Monocykliska beta-laktamer med antibakteriell aktivitet
SE7707366L (sv) Forfarande for framstellning av 7alfa-metoxi-cefalosporansyraderivat

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7612295-1

Format of ref document f/p: F